Results 41 to 50 of about 11,360 (191)

The neglected majority: Inverse relationship between prevalence and global research activity of 15 dermatological diseases

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Oliver Brandt   +3 more
wiley   +1 more source

Antileishmanial Activities of Carvacrol Nanoencapsulate in Biopolymeric Nanoparticles

open access: yesChemistry &Biodiversity, Volume 22, Issue 9, September 2025.
The study obtained biopolymeric nanoparticles containing carvacrol (NPCar) and evaluated their anti‐leishmanial activity. NPCar obtained presented physicochemical characteristics due to its ideal nanometric size and zeta potential, and low polydispersity index.
Joyce Cordeiro Borges   +6 more
wiley   +1 more source

Contribución al estudio epidemiológico del kala-azar en Colombia

open access: yesRevista de la Facultad de Medicina, 1971
Los autores informan sobre el estudio epidemiológico del kala-azar en un foco situado en el municipio de Melgar, departamento del Tolima. Colombia. Encontraron la modalidad del kala-azar de la zona neotropical descrita en otras partes de América; mayor ...
Augusto Corredor Arjona   +2 more
doaj  

Atypical Manifestations of Old World Cutaneous Leishmaniasis: A Systematic Review and Clinical Atlas of Unusual Clinical and Specific Anatomical Presentations

open access: yesHealth Science Reports, Volume 8, Issue 9, September 2025.
ABSTRACT Background and Aims Cutaneous leishmaniasis (CL) represents the most common form of leishmaniasis. It imposes a significant medical burden due to long‐lasting ulcers and disfiguring scars, underscoring the need for comprehensive CL control strategies, particularly in endemic regions.
Bahareh Abtahi‐Naeini   +5 more
wiley   +1 more source

Oxidative Stress and Antioxidant Status in Human InfectedWith Kala-azar

open access: yesAl-Mustansiriyah Journal of Pharmaceutical Sciences, 2009
Malondialdehyde (MDA) is the most commonly marker that is used to investigate the presence of oxidative stress in biological system, and glutathione redox cycle is a major antioxidant defense system for the detoxification of reactive oxygen species (ROS)
Basma Talib Jasim, Ahmed A. M. Al-Azzauy
doaj   +1 more source

STUDY OF VISCERAL LEISHMANIASIS (KALAAZAR) CASES IN TEHRAN, NECESSITY OF EARLY DIAGNOSIS AND PREVENTION

open access: yesIranian Journal of Public Health, 1999
Thirty eight patients with visceral Leishmaniasis were reviewed, age ranged from 2 months to 10 years, 74% above 3.5 y, with 24% affection in infants (7 to 12 m), with slight male predilection.
M. jalali   +3 more
doaj  

Climate Change and Environmental Influence on Prevalence of Visceral Leishmaniasis in West Pokot County, Kenya

open access: yesJournal of Tropical Medicine, 2022
Kala-azar is a parasitic disease caused by Leishmania species transmitted by sand fly. In Kenya, kala-azar is endemic in thirty subcounties spread over in eleven counties in the arid zones.
Bulle Abdullahi   +5 more
doaj   +1 more source

Efficient and Rapid Arylation of NH₂‐Unprotected Bromobisindole Ethanamines via Suzuki‐Miyaura Coupling: Generating New Leads Against Leishmania

open access: yesChemistry – A European Journal, Volume 31, Issue 43, August 1, 2025.
A library of novel bisindole derivatives was synthesized through an optimized rapid Suzuki‐Miyaura coupling reaction, utilizing NH2‐unprotected bromobisindole ethanamines and boronic acids with yields up to 93%. The compounds were screened for their activity against L. infantum promastigotes.
Alessandro Buono   +8 more
wiley   +1 more source

Effectiveness of an Intervention in Improving Knowledge and Practices about Kala-azar in a Tribal Population of Eastern India

open access: yesJournal of Primary Care Specialties
Background: Kala-azar, or visceral leishmaniasis, caused by Leishmania donovani, remains a significant health concern in India and other endemic regions.
Pritama Paul   +4 more
doaj   +1 more source

Appraising the visibility, relevance and impacts of clinical pharmacology

open access: yesBritish Journal of Clinical Pharmacology, Volume 91, Issue 7, Page 1884-1898, July 2025.
Aims Clinical pharmacology (CP) used to be a strong medical and scientific field, but during the last three decades it seems to have lost some of its appeal. We reviewed the visibility, relevance and impact of CP and clinical pharmacologists across the globe and suggest ways to strengthen the discipline to address future pharmacotherapeutic challenges.
Serge Cremers   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy